PharVision Advisers’s Energy Recovery ERII Stock Holding History

PharVision Advisers’s Portfolio ERII Stock Details ERII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-16,155	Closed	-$206K	–	704
2025 Q2	$206K	Buy	+16,155	New	+$219K	0.3%	196

Other funds holding ERII

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return

Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return

PharVision Advisers's ERII Position: Q3 2025 in Review

PharVision Advisers sold out of Energy Recovery (ERII) in Q3 2025, closing a stake of 16,155 shares — an estimated $206K sold.

PharVision Advisers first reported a position in ERII in Q2 2025 and held it in 1 quarter. The position peaked at $206K in Q2 2025. 192 funds tracked by Wall St. Rank hold ERII as of Q3 2025.

PharVision Advisers reported no remaining Energy Recovery position as of Q3 2025 after selling out during the quarter.
PharVision Advisers sold 16,155 Energy Recovery shares in Q3 2025, an estimated $206K.
PharVision Advisers first reported a position in Energy Recovery in Q2 2025 and held it in 1 quarter.
PharVision Advisers's Energy Recovery position peaked at $206K in Q2 2025.
192 funds tracked by Wall St. Rank held Energy Recovery as of Q3 2025.

Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.